Business Description
Zeria Pharmaceutical Co Ltd
ISIN : JP3428850006
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.57 | |||||
Equity-to-Asset | 0.56 | |||||
Debt-to-Equity | 0.48 | |||||
Debt-to-EBITDA | 2.82 | |||||
Interest Coverage | 23.18 | |||||
Piotroski F-Score | 9/9 | |||||
Altman Z-Score | 2.32 | |||||
Beneish M-Score | -2.44 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 14.5 | |||||
3-Year EBITDA Growth Rate | 28.5 | |||||
3-Year EPS without NRI Growth Rate | 41.7 | |||||
3-Year Book Growth Rate | 13.8 | |||||
Future 3-5Y EPS without NRI Growth Rate | 15.54 | |||||
Future 3-5Y Total Revenue Growth Rate | 8.79 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.2 | |||||
Quick Ratio | 0.92 | |||||
Cash Ratio | 0.45 | |||||
Days Inventory | 241.63 | |||||
Days Sales Outstanding | 102.13 | |||||
Days Payable | 56.12 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Dividend Growth Rate | 9 | |||||
3-Year Average Share Buyback Ratio | 1.2 | |||||
Shareholder Yield % | 5.7 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 73 | |||||
Operating Margin % | 13.2 | |||||
Net Margin % | 10.31 | |||||
ROE % | 10.43 | |||||
ROA % | 5.5 | |||||
ROIC % | 5.9 | |||||
ROC (Joel Greenblatt) % | 23.2 | |||||
ROCE % | 11.52 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 12.76 | |||||
Forward PE Ratio | 10.8 | |||||
PE Ratio without NRI | 12.51 | |||||
Shiller PE Ratio | 23.71 | |||||
PEG Ratio | 0.68 | |||||
PS Ratio | 1.32 | |||||
PB Ratio | 1.21 | |||||
Price-to-Free-Cash-Flow | 12.93 | |||||
Price-to-Operating-Cash-Flow | 8.8 | |||||
EV-to-EBIT | 11.08 | |||||
EV-to-EBITDA | 8.32 | |||||
EV-to-Revenue | 1.54 | |||||
EV-to-FCF | 15.13 | |||||
Earnings Yield (Greenblatt) % | 9.03 | |||||
FCF Yield % | 7.73 | |||||
Forward Rate of Return (Yacktman) % | 22.48 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with GREY:ZRPHF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Zeria Pharmaceutical Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | 0.46 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 0 | ||
14-Day ATR ($) | 0 | ||
20-Day SMA ($) | 0 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range ($) | 0 - 0 | ||
Shares Outstanding (Mil) | 46.29 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Zeria Pharmaceutical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Zeria Pharmaceutical Co Ltd Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Zeria Pharmaceutical Co Ltd Frequently Asked Questions
What is Zeria Pharmaceutical Co Ltd(ZRPHF)'s stock price today?
When is next earnings date of Zeria Pharmaceutical Co Ltd(ZRPHF)?
Does Zeria Pharmaceutical Co Ltd(ZRPHF) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |